Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

NCT01444352 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.

NCT NCT01444352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01444352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2010
Completion date
January 31, 2011
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal infections, pneumococcal pneumonia, streptococcus pneumoniae infections